Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.665
+0.055 (3.42%)
Feb 4, 2025, 12:09 PM EST
Talis Biomedical Market Cap
Talis Biomedical has a market cap or net worth of $3.03 million as of February 5, 2025. Its market cap has decreased by -78.24% in one year.
Market Cap
3.03M
Enterprise Value
-38.03M
Revenue
408.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.67
Market Cap Chart
Since February 12, 2021, Talis Biomedical's market cap has decreased from 652.79M to 3.03M, a decrease of -99.54%. That is a compound annual growth rate of -74.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 3.03M | -5.34% |
| Dec 31, 2024 | 3.21M | -76.37% |
| Dec 29, 2023 | 13.57M | 13.66% |
| Dec 30, 2022 | 11.94M | -88.68% |
| Dec 31, 2021 | 105.42M | -83.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.12B |
| SS Innovations International | 1.62B |
| Veradigm | 847.75M |
| Elite Pharmaceuticals | 539.42M |
| Glass House Brands | 422.94M |
| Northwest Biotherapeutics | 375.11M |
| BioStem Technologies | 246.65M |
| Nika Pharmaceuticals | 246.33M |